Home > Press > Nanopatch team’s Eureka moment
Abstract:
A multidisciplinary team comprised of researchers from UQ and the University of Melbourne was selected as a finalist for the Research by an Interdisciplinary Team category of the recent Australian Museum Eureka Prizes.
Spearheaded by the Australian Institute for Bioengineering and Nanotechnology's (AIBN) Professor Mark Kendall, the team brings together researchers in the areas of engineering, materials science, imaging, virology, immunology, and vaccinology.
"The team is working to develop a cheap, easy to use, painless, needle-free nanopatch to rival the traditional needle and syringe as the preferred method for delivering vaccines into the human body," Professor Kendall said.
"The needle and syringe was invented in 1853 and has not changed since - in fact it is not particularly efficient at delivering a vaccine payload to immune cells and as a result is inhibiting the development of more advanced vaccines.
"Our project, with its focus on targeting and delivering a vaccine to the immune cells just below the surface of the skin, requires an in depth understanding of the mechanical properties of skin, human immune responses, novel fabrication techniques and vaccine development to name a few.
"Without the expertise of Professors Ian Frazer (Director of UQ's Diamantina Institute), Michael Roberts (Director of UQ's Therapeutic Research Unit in the School of Medicine and Professor of Therapeutics & Pharmaceutical Sciences, University of South Australia) and Lorena Brown (University of Melbourne) and their teams it is doubtful that research would have progressed to its current stage.
"Unfortunately we did not win the Prize, but to be one of just three finalists was a great achievement, particularly in light of the high quality applications," he said.
The Interdisciplinary Team category recognises an Australian research partnership, group or team for a ground breaking research outcome that has involved collaboration and integration between researchers from two or more unrelated disciplines.
The Eureka Prizes are presented annually by the Australian Museum and reward excellence in the fields of scientific research, innovation, science leadership, school science and science journalism & communication.
More information here www.aibn.uq.edu.au/index.html?page=44481
####
For more information, please click here
Contacts:
Media contact
Professor Mark Kendall
0431 162 391
Copyright © Australian Institute for Bioengineering and Nanotechnology
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||